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ABSTRACT 
Background: Medical device development projects must follow 
proper directives and regulations to be able to market and sell 
the end-product in their respective territories. The regulations 
describe requirements that seem to be opposite to efficient 
software development and short time-to-market. As agile 
approaches, like DevOps, are becoming more and more popular 
in software industry, a discrepancy between these modern 
methods and traditional regulated development has been 
reported. Although examples of successful adoption in this 
context exist, the research is sparse. Aims: The objective of this 
study is twofold: to review the current state of DevOps adoption 
in regulated medical device environment; and to propose a 
checklist based on that review for introducing DevOps in that 
context. Method: A multivocal literature review is performed 
and evidence is synthesized from sources published between 
2015 to March of 2020 to capture the opinions of experts and 
community in this field. Results: Our findings reveal that 
adoption of DevOps in a regulated medical device environment 
such as ISO 13485 has its challenges, but potential benefits may 
outweigh those in areas such as regulatory, compliance, security, 
organizational and technical. Conclusion: DevOps for regulated 
medical device environments is a highly appealing approach as 
compared to traditional methods and could be particularly suited 
for regulated medical development. However, an organization 
must properly anchor a transition to DevOps in top-level 
management and be supportive in the initial phase utilizing 
professional coaching and space for iterative learning; as such an 
initiative is a complex organizational and technical task. 
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1  INTRODUCTION 
Regulated industries are environments where the product or 
service must comply with external requirements concerning 
security, safety, human criticality or mission criticality. Since 
2010, software is being treated as an active medical device in the 
European Union (EU) [10]. Therefore, software development 
process in regulated industries requires careful considerations 
during its lifecycle. Increased risk awareness and enforced 
regulative requirements require a software development process 
that has domain-specific properties encoded. Since 2015, the 
United Nations Sustainable Development Goals [26] have 
promoted new product developments, which in turn require 
attention to process decisions in companies as they can fall 
under regulated areas of development. In particular, goal 3 states 
bold requirements for the future of health and well-being. In this 
context, introducing DevOps to regulated software development 
might fit into the space of converting concepts and bold ideas to 
reality. 
Within medical device development in the EU and other 
territories, the established route to fulfilling the Medical Device 
Directive [9] is to implement a quality management system 
(QMS) based on a harmonized standard like ISO 13485:2016. 
Thus, ISO 13485:2016 [30] specifics requirements to different 
parts of an organization developing, producing or selling medical 
devices. In fact, the organization does not need to include all 
requirements in its QMS, it depends on the nature of the medical 
device or the role of the organization as a developer, 
manufacturer or distributor of medical devices [14]. The 
implementation of a QMS must be approved by a Notified Body 
and periodically reviewed for compliance. Therefore, such an 
implementation has to take into account the need for objective 
evidence during all phases of a product's lifetime and be properly 
anchored in company management. Software, regardless of its 
use in a medical device or as a standalone solution, is classified 
as an active medical device [21]. A software product used for 
therapeutic purposes (like mobile apps, cloud solutions or even 
Excel spreadsheets) falls under the regulative requirements. 
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The software industry, in general, has little or no regulative 
requirements enforced. Software development approaches are 
dynamic nature, and implementations tend to adopt to the 
context, following industry trends and community. In particular, 
DevOps has become a popular approach where agile principles 
and operational concerns converge. Merging the static nature of 
regulated environments with the dynamic nature of DevOps 
requires considerations as this has potential implications on 
methods, methodologies, frameworks and tools chosen. 
According to [15]: One characteristic of regulated environments is 
the multitude of compliance procedures, regulations and standards 
that have to be considered in the software development process. 
There are discrepancies between these regulated and un-
regulated environments and how they adopt industry software 
development trends [16]. In fact, agile approaches for regulated 
medical device software development are gaining attention from 
researchers and practitioners due to their potential benefits 
[6,16,21]. Thus, merging DevOps and compliance brings promise 
of shorter time to market, better quality and safer products 
through iterative and incremental change. 
The objective of this study is to review the current state of 
DevOps adoption in regulated medical device environments and 
propose a checklist for introducing DevOps in that context. 
1.1  Iterative and Incremental Change 
In 2001, Beck et al. [4] introduced 12 basic principles for 
software development through the "Agile Manifesto", 
summarized as these core key values: 
1. Individuals and interactions, over processes and tools. 
2. Working software, over comprehensive documentation. 
3. Customer collaboration, over contract negotiation. 
4. Responding to change, over following a plan. 
Being agile is to embrace change and produce no document unless 
it’s immediate and significant [20]. In its simplest form, carrying 
out change in a regulated development process can be seen as an 
exercise of the Plan-Do-Check-Act cycle, repeated until a defined 
stop criterion (e.g. fulfill the requirements to the product). This 
way of iterative and incremental change can be formalized using 
approaches like eXtreme Programming (XP), Scrum, Disciplined 
Agile Delivery (DAD), Agile Modeling (AM), Dynamic Systems 
Development (DSDM) and Feature Driven Development (FDD) 
[21]. However, medical device development goes beyond initial 
product deployment into service and de-commissioning phases 
and need to be effective also in the operational and post-delivery 
phases. In this context, DevOps becomes a popular alternative 
due to its operational nature. 
Formalizing the change management process according to 
medical device standards enforce requirements for effective 
traceability. In consequence, all the aspects of updating product 
state must be recorded so that objective evidence can be traced 
back to every change emerged during a product's lifetime. All 
actions linked to the outcome of product quality must be under 
control, as defined by the standards. Using DevOps as a process 
approach is now a popular way to combine iterative 
development and continuous deployment [12]. Thus, the need to 
evaluate DevOps for medical development arises as DevOps 
could complement frameworks such as V-models and waterfall-
models defined in the guidelines for standards implementation. 
1.2  DevOps 
Although there is no single conformed definition of DevOps, 
earlier literature describes it as the conceptual and operational 
merging of development and operations' needs, teams, and 
technologies [7]. Recent publications define DevOps as practices 
that reduce and join repetitive tasks with automation in 
development, integration, and deployment [17]. Based on our 
understanding of the regulative requirements for a complete life-
cycle method for medical device software, a DevOps approach 
might hold a promise for more appropriate process 
implementations. 
1.3  Research Needs 
Attention to challenges and benefits from introducing DevOps in 
an ISO 13485 context is fundamental when assessing whether 
DevOps can be introduced as a development approach. This 
paper investigates and identifies DevOps implementation 
challenges, benefits and strategies in regulated medical device 
industries by doing a Multivocal Literature Review (MVLR) on 
primary studies and including Grey Literature (GL). GL are 
sources outside the scholarly literature reflecting experience and 
opinions of industry experts and practitioners (e.g. blog posts, 
videos, whitepapers). 
An initial search for secondary studies yielded few results but 
a recent literature survey was presented by Laukkarinen et al. 
[17]. They discuss DevOps practices and tools in regulated 
software development and describe some improvements in 
tooling, documentation and regulative requirements are 
necessary. Their survey builds upon [16] that discuss application 
of IEC 62304 and IEC 82304-1 and compares conflicting 
compliance requirements with DevOps but aspects related to 
developer and company cultures are not investigated. Although, 
we did not find studies including GL with the same objectives as 
our MVLR, there are studies discussing other aspects, e.g. 
security in DevOps [22], the relationship of DevOps to Agile, 
Lean and Continuous Deployment [19], and the use of DevOps 
for e-learning systems [25]. 
In addition, it is worth noting that IEC 62304 [23] and IEC 
82304-1 [29] are non-harmonized standards for regulated 
medical software development. Based on company context these 
or other standards may apply, so they are relevant when 
identifying sources. An approved QMS is per definition 
following the directives, if a harmonized standard like ISO 13485 
is applied. However, there are situations where other quality 
standards are used. For instance, the US Food and Drug 
Administration requires one to comply with its Quality System 
Regulation (FDA QSR) and the GMx-portfolio have their own 
ISO 13485-extensions. Our MVLR is based on ISO 13485 as to 
identify relevant sources about medical device development, 
although not all sources explicitly state relation to this standard. 
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1.4 Related works 
The closest related work was carried out by Laukkarinen et al. 
[17]. These authors claim that lean and agile methods (which 
DevOps fall under) may be more prone to errors ending up in 
the final product, but with faster recovery time. On the contrary, 
our findings reveal that DevOps is reported even more suited for 
making high-quality software. In this context, software 
development should support multiple feature streams to be 
effective although no feature can be released without all 
activities are completed (IEC 62304 Chapter 5.8.1). Agile 
approaches, in particular DevOps, support this natively through 
code organization, branching and story-mapping, as well as 
automated testing and code-first strategies. 
Laukkarinen et al. [17] also conclude that the development 
team could use continuous delivery internally and produce 
documentation for regulatory inspection, a view supported in 
the multiple-case study carried out by Wagenaar et al. [28]. They 
identified that mostly test-related artifacts are shared in this 
way. In this sense, our findings indicate that regulators should be 
treated as stakeholders in the DevOps process itself, rather than 
just external partners. 
Laukkarinen et al. [17] summarize standard practices like 
item tracking across tools, standard templates, hierarchical 
traceability and developer workflow tools for compliance. 
Although we found that regulated DevOps share characteristics 
with traditional DevOps, considerations necessary for bridging 
DevOps in medical device product development could be 
extensions to existing processes, not contradictions [27]. Our 
MVLR supports these claims, with blockchain technology and 
code-first strategies as a natural evolution. 
2  METHODOLOGY 
We conducted a multivocal literature review as proposed by [11] 
on primary studies and GL. GL allows us to review the industry 
experience that is not reported in the academic literature. In 
what follows, we present the research questions and the study 
protocol that guide our review process. 
2.1  Research Questions 
The research questions must be seen in the context of regulated 
software development under ISO 13485 and other applicable 
standards. 
RQ1: Is there evidence in the sources of the usage of DevOps 
in regulated medical devices environments? 
RQ2: What challenges and benefits are reported in the 
sources about DevOps in regulated medical device 
environments? 
RQ2.1: Is there any reported evidence of shorter verification 
and validation cycles in the medical device industry using 
DevOps? 
RQ3: What DevOps practices are in use in regulated medical 
device environment studied in the sources? 
RQ3.1: How are DevOps practices extended to ensure 
regulatory compliance? 
RQ4: What organizational and operational strategies and 
factors should be considered when DevOps and ISO 13485 are 
implemented? 
Descriptive and qualitative data synthesis will be used during 
evidence accumulation. The results of RQ3 and RQ3.1 share 
much of the same context and it is therefore reported as a 
merged RQ3/3.1: What DevOps practices and extensions are in use 
in regulated medical device environment that enables compliance? 
2.2  Study Protocol 
The protocol describes the way literature is systematically 
gathered and the criteria for including sources of data. All results 
are shared on Figshare [18] for transparency, reproducibility and 
replicability . 
2.2.1 Index sources. The following search engines have been 
used for conducting searches: IEEE Xplore, ACM Digital Library, 
ScienceDirect, Wiley Online Library, SpringerLink, Google 
Scholar and Google Web Search. For each one, the following 
search strings were formulated: 
devops AND ISO AND 13485 
devops AND regulated AND development 
devops AND regulated AND (development OR environment 
OR software) 
In total, 7.639.431 search hits. The search was conducted on 
March 5th 2020. The last two search strings are very similar and 
reported nearly exactly the same search counts with mostly 
duplicates. 
2.2.2 Search stopping criteria. Google Scholar and Google Web 
Searches are stopped when reaching theoretical saturation (no 
more relevant sources appear) and effort bounded, 
corresponding to the first five pages of both sources [11]. 
Inaccessible sources or sources not responding are excluded. 
After applying the search stop criteria, results from the sources 
were catalogued using the tool Paperpile [31] and Airtable [32]. 
Finally, 1120 sources were collected. 
2.2.3 Automatic duplicate source merge. Paperpile did an 
automatic duplicate removal by merging sources with the merge 
duplicates tool, by comparing meta-data of the sources. After this 
process, 566 sources remained. 
2.2.4 Inclusion criteria. A manual skim-through of all 
remaining source's title, abstract, first few paragraphs or first 
few frames of videos were done and the following inclusion 
criteria applied:  
1. All search result outlet types (articles, books, magazines, 
theses, reports, white papers, news articles, presentations, 
videos, discussion forums, wiki articles, and blogs). 
2. Literature discussing DevOps and relevant to the regulated 
medical device industry or literature discussing ISO 13485, 
IEC 82304-1 or IEC 62304 implementation in software 
development. 
73 sources remain after this step. For each source, the article 
PDF was retrieved, or in the case of GL, a PDF was created by 
using the Print web page ⸺function in Google Chrome and/or 
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accompanying white papers/presentations downloaded and 
stored in Paperpile. 
2.2.5 Exclusion criteria. The remaining sources were analyzed 
and excluded according to the criteria: 
1. Sources without date or published year and author or 
organization. 
2. Sources dated older than the year 2015. 
3. Duplicates and similar data sources (same sources published 
at multiple sites). 
4. Secondary studies such as systematic literature reviews 
(SLRs), multivocal literature reviews (MVLRs) or mappings. 
5. Vendor advertisements. 
6. Search result pages in other search engines. 
7. Course or event invitations. 
8. People and company directories. 
After the exclusion process step, 39 sources remain. 
2.2.6 Quality assessment criteria. GL sources are classified 
according to quality assessment criteria. The following quality 
assessment criteria is used (subset from [11]): 
1. Is the publishing organization identifiable and reputable? 
(Yes=1.0, No=0.0) 
2. Is the author associated with the publishing organization? 
(Yes=0.5, No=1.0, No author=0.0) 
3. Does the author have expertise in the area? (e.g., job title 
Principal Software Engineer or Quality Manager)? (Yes=1.0, 
No=0.0) 
4. Does the work seem to be balanced in presentation? 
(Yes=1.0, No=0.0) 
5. Is there any backup evidence to statements in the work? 
(Yes=1.0, No=0.0) 
6. Does it strengthen or refute a current position? (Yes=1.0, 
No=0.0) 
7. Are the statements of a subjective opinion? (Yes=0.0, 
No=1.0) 
8. Which outlet control has the material (high=1.0 / 
moderate=0.5 / low=0.0, where high=Books, magazines, theses, 
government reports, whitepapers; moderate=Annual reports, 
news articles, presentations, videos, Q/A sites, Wiki articles; 
and low=Blogs, emails, tweets). 
The set of answers was summarized and normalized, and a 
quality assessment score 0-1 was calculated. Sources with a 
normalized quality assessment criterion score greater than 0.5 
were included (see details in [18], dataset named extracted). As a 
result, 23 sources remain after this step. 
2.2.7 Snowballing. Snowballing is a technique to follow 
references from included sources and perform another 
inclusion/exclusion operation on those and possibly include the 
result in the evidence pool if they pass the quality assessment 
criteria. This is done during full-text reading and data extraction. 
Ultimately, 3 sources were included as a result of snowballing, 
inclusion/exclusion and quality assessment. 
2.2.8 Data extraction. Paperpile is a simplified reference 
management system that allows to store all sources in a personal 
Google Drive and to share them with other authors. Paperpile 
was also used for metadata retrieval, citing tool, duplicate 
removal and initial inclusion classification. Airtable was used as 
an online spreadsheet to classify each source according to the 
exclusion criteria, quality assessment and research questions. 
Figshare is used for permanent source and quotation storage.  
2.2.9 Search execution process. The search was conducted on 
March 5th 2020 and gave 26 extracted sources from all databases 
according to the process shown in Figure 1. In fact, we provide 
three datasets that are available on Figshare [18]: 1) sources list; 
2) extracted data including exclusion criteria and quality 
assessment; and 3) the extracted quotations. All 26 sources along 
with their quotations are also listed in the appendix A. The 
quotation identifier [ID-number] is referenced as source-quote in 
the third dataset. Most of the sources are related to multiple 
quotes so the total number of quotes (79) is larger than the 
number of sources (26). 
 
 
Figure 1: Search and extraction process 
In this review, two of the authors were involved in the 
selection process while the other author reviewed the process 
and results. Each selected source was read by two authors; in the 
case of disagreement, a third author was involved in the 
discussion to reach consensus. 
3 RESULTS 
An initial analysis of the sources revealed mostly qualitative 
references as expected. Therefore, we employ an approach for 
synthesizing the evidence that was inspired by descriptive 
(narrative) synthesis as well as case and acceptance 
argumentation schemes based on expert and popular opinions 
[24]. 
RQ1: Is there evidence in the sources of the 
usage of DevOps in regulated medical 
devices environments? 
As organizations should adhere to a harmonized ISO 13485 
standard in the EU, IEC 62304 and/or IEC 82304-1 are non-
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harmonized standards that should be incorporated into the QMS 
when developing medical grade software. When working under 
the EU Medical Device Directive (MDD), employing the ISO 
13485 standard in the organization also means you follow the 
directives, if the organization's QMS (or parts of it) is approved 
by a Notified Body. We would thus assume that organizations 
that have an approved QMS, also follow IEC 62304/IEC 83404-1 
and ISO 13485. Reference to any of these standards could 
indicate a source with such knowledge. However, there is no 
explicit evidence in the sources of approved QMSs using DevOps 
that supports this. 
The IEC 82304-1 applies to healthcare software that is 
designed to operate on IT platforms without dedicated hardware, 
e.g. mobile applications on tablets and phones. The IEC 62304 
standard should be met when developing software for medical 
devices. Regardless of development process approach, the IEC 
62304 standard provides a framework of life cycle processes with 
activities and tasks necessary for the safe design and maintenance 
of medical device software (page 11 of the 2006 French/English 
standard), whereas the IEC 82304-1 includes different intended 
use and other steps in the software lifecycle. Four source-quotes 
[ID1, ID8, ID10, ID11] present results and analysis that indicates 
knowledge in medical device development and DevOps. No 
sources explicitly state reference of the use of these standards, 
but they still claim to develop medical graded software. 
In this sense, although a DevOps process itself must be 
described in an organization's QMS or work instructions, only 
one source [ID6] describes such a link properly, and the proposal 
seems to be interesting. By mapping processes and 
documentation through a simple document interface, the Q-
interface, a lean quality process is achieved across several units. 
Q-interface is an easy-to-use document that does not replace QMS 
but guides distributed teams across India, the USA, and Germany 
towards a standard set of tools, processes, methods, and procedures 
and maps them to respective QMS [ID6]. One can conclude that 
the use of DevOps might be seen as an implementation of QMS 
work instructions, a claim supported in [ID5]. This would mean 
that the DevOps process itself not necessarily is subjected to 
regulatory approval but must fulfill requirements in such 
approved QMS and be documented locally in work instructions. 
Underlying trends in the industry is to move faster and adopt 
new methods, facilitated by shorter release cycles and breaking 
down silos between development and operation (DevOps). 
According to the 2019 DevSecOps Community Survey (cited in 
[ID2]), DevOps is gaining importance in banking, telecom and 
retail areas but healthcare is a slow mover. In fact, [ID3, ID4] 
reveals that healthcare is, in fact, undergoing a silent move 
towards DevOps and shorter release cycles. 
RQ2: What challenges and benefits are reported 
in the sources about DevOps in regulated 
medical device environments? 
There are challenges, but also numerous benefits when 
evaluating the outcome. These are presented grouped into seven 
categories. 
Regulatory challenges. With regards to regulatory 
challenges, the following have been reported: conflicting 
security policies, protection of intellectual properties, open 
communication, cross-collaboration and continuous end user 
feedback [ID12] as well as exposure to potential additional risks 
[ID27]. However, it is also reported [ID29] that DevOps is a good 
fit for developing medical devices. A part of a DevOps strategy 
could be to leverage cloud-native application support for QMS 
processes and the medical application development itself, and 
thereby enabling better support for e.g. data science through big 
data and elastic computation [ID18]. Another challenge could be 
maintaining traceability across all levels of code branches, 
requirements and software items must be maintained when 
using several QMS support tools [ID28]. In other words, 
maintaining proper software item identification and audit trails 
across specialized domain tools is a challenge [ID20] that needs 
to be addressed. 
Organizational challenges. Changing an organizational 
culture to transition from traditional development to DevOps is 
considered the biggest obstacle one will likely encounter [ID12, 
ID19, ID26]. Likely, organizational training and coaching and 
even changing the work structure are necessary. Shorter release 
cycles mean more planning activities, more collaboration and 
harmonizing processes and milestones across organizational 
entities [ID21, ID23]. An increased volume of test activities, 
overlapping activities and a rapid change of requirements are 
consequences that must be organizationally addressed [ID24] by 
adding more resources as necessary. Harmonizing DevOps with 
the processes, activities and tasks defined in standards such as 
the IEC 62304 is a complex and challenging endeavor [ID20] that 
should be achievable. In RQ4, we propose a checklist of 
organizational and operational strategies and factors that should 
be considered when DevOps is implemented in a regulated 
medical device environment such as ISO 13485. 
Technical challenges. In medical device development, no 
feature can be released (and deployed) before it is approved 
according to the quality procedures of the organization's QMS. 
Depending on software item risk classification, IEC 62304 
defines numerous levels of verification and validation tasks 
necessary to complete before feature release. In contrast, the 
short release cycle philosophy of DevOps is a hurdle against a 
DevOps approach [ID13] as code branches should not be merged 
without feature approval. Teams must support multiple streams 
of functionality [ID16] and be able to handle several levels of 
gradually completed functionality, and several branches of 
source code. Increasing complexity of test environments is a 
major challenge when verification tasks must be done on each 
separate feature streams, especially if long running stability tests 
occupy limited hardware resources [ID16]. 
Environment visibility and security. DevOps has 
challenges particularly concerned with deployment and 
verification in embedded systems, depending on the feature 
complexity as discussed above. An organization must address 
challenges related to hardware dependency and limited visibility 
to customer environments while it is observant to the possibility 
of getting usage data from customer environments [ID22]. 
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According to [ID25, ID14], highly regulated development is 
traditionally organized in isolated silos, making collaboration on 
centralized repositories harder and complicate the deployments 
into production environments. Restrictions on network security 
and integration with external partners in product development 
[ID15] further complicate the collaboration activities. 
Regulatory benefits. According to [ID30], DevOps is vital 
for being able to adapt new regulations, and therefore increase 
competitive capabilities for companies. Over the years, new 
standard revisions and updated regulations (and new approval 
requirements) must be implemented in existing QMSs. DevOps 
also brings continuous focus on areas of risk management and 
safety [ID31], and DevOps is seen as superior to previous 
development frameworks [ID33]. Thus, DevOps could enable 
higher quality software development and adoption of the 
software development process to changing contexts [ID31]. 
Organizational benefits. Implementing DevOps means 
continuous backlog prioritization and quality assessment which 
may lead to earlier delivery of products and organizational 
improvements, as well as increased flexibility in activity 
planning [ID31, ID32]. As DevOps promotes, and heavily relies 
on collaboration, different roles and responsibilities will be 
involved and coordinated [ID32]. 
Technical benefits. DevOps is also seen as prerequisites for 
supporting the next wave of architectural patterns: microservices 
architecture, containerization, and cloud services [ID33]. Going 
cloud-native and utilizing containerization where possible could 
mean that long running verification tasks could be moved to 
environments with less hardware resource constraints. In this 
case, a medical device is a pure-software service. 
RQ2.1: Is there any reported evidence of shorter 
verification and validation cycles in the 
medical device industry using DevOps? 
It was reported by academic literature that introducing DevOps 
in medical device development leads to several improvements 
compared to traditional development: feedback loops are 
extended and accelerated [ID35]; reduction of cost in time and 
human resources [ID36]; and a reduction in defects [ID37] which 
could lead to both better quality and better suited fulfillment of 
user needs. The last study [ID37] compares up-front planning 
with exploratory development in four companies using their 
Hybrid MDevSPICE® process assessment framework. These 
authors propose a formal framework for transition to agile 
approaches. All three studies describe practices and challenges 
related to specific industry projects and companies. 
Infrastructure automation. Shortening the software 
development cycle is additionally enabled by implementing 
automated infrastructure management (infrastructure-as-code). In 
this way, defects and updates are addressed in a more efficient 
manner through shorter cycles, tight collaboration and frequent 
updates. In particular, decreased time to market is a major 
advantage [ID39]. 
Blockchain. An emerging idea is to introduce blockchain 
technology when setting up the automation part of DevOps, as 
proposed by the software company Cognizant [ID40] and later 
by [1]. According to [ID40], a blockchain-based enterprise DevOps 
solution can both accelerate application delivery and comply with 
regulatory requirements. Smart contracts introduce the concept of 
compliance as code by validating entry and exit points on various 
levels in the application delivery pipeline. Moreover, it was 
estimated up to 70% reduction in release timelines while at the 
same time enabling more effective regulatory compliance 
through blockchain automation. 
RQ3/3.1: What DevOps practices and extensions 
are in use in regulated medical device 
environment that enables compliance? 
Using DevOps in medical device development shares 
characteristics with the traditional DevOps architecture [8]: 
more automation, tools and testing as well as short planning 
cycles and structured requirements management. In [ID41], 
automated verification activities were implemented by using 
new tooling in order to introduce a Continuous Integration / 
Continuous Delivery (CI/CD) process in a medical device 
development. Moreover, the view of focusing on maintaining a 
robust CI/CD stack and automate tasks where possible is 
supported in [ID43]. 
Infrastructure as Code. Another step to enforce regulatory 
compliance is implementation of infrastructure-as-code (IaC). 
This allows organizations to automate configuration changes by 
making them repeatable and standardized [ID44]. In light of IEC 
62304 Chapter 8.1, IaC can be interpreted as configuration items 
that must be identified, version controlled and securely 
controlled. Therefore, requirements for traceability are also 
enforced to these types of artifacts. 
IaC is enabled by new containerization and virtualization 
technologies as well as by microservice architectures, and it is 
also reported to have a positive impact [ID44]. Thus, IaC should 
be seen an enabler of DevOps in this context. However, proper 
compliance arrangements with the infrastructure suppliers must 
be considered when utilizing commercial off-the-shelf services 
like Kubernetes and cloud microservices in a medical context 
[ID45]. 
Compliance. An interesting finding is that most sources 
describe DevOps outcomes as positive for regulated development 
(the artifact generation and development process), but important 
aspects regarding regulatory compliance of DevOps itself is 
scarcely mentioned except for [ID46]. The analysis presented in 
this paper covers issues that must be addressed if conformance 
to IEC 62304 and ISO 13485 is to be claimed by an organization. 
The analysis notes specific contradictions between IEC 62304 
and DevOps [ID46]:  
1. Clause 5.5.3: All software units must meet verification 
acceptance criteria before entering integration activities and 
integration testing. In DevOps, unit testing must be 
completed before integration takes place. 
2. Clause 5.8.5: The procedure and the environment of 
software creation must be documented. In DevOps, this 
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puts requirements on tooling and tool validation, outlined 
in a Software Validation Plan as described by a QMS. 
3. Clause 5.8.6 requires all tasks and activities to be completed 
before the software is released. In DevOps, long-living 
source code branches must be handled properly.  
4. Clause 5.8.8 requires that the software release must be 
repeatable. In DevOps, it could be enabled by 
infrastructure-as-code and dockerization, virtualization. 
5. Clause 8. Requires management of configuration items, 
identifiers and version control. In DevOps, tight tool 
integration and artifact management is necessary. 
With this background, there are several extensions found 
from analysis of the sources. The most notable practices that 
extend DevOps in regulated development are: 
1. Implement solid testing principles and test automation 
[ID47] and automated delivery pipelines [ID48]. 
2. View auditors as stakeholders in DevOps [ID48]. 
3. Codify compliance requirements and policies (IaC) 
[ID48].Compliance policies and controlled workflows help 
to improve pipeline velocity [ID79] when defining 
compliance as part of the workflow. 
4. Combine DevOps (and/or other agile approaches) and plan-
based elements in hybrid “mini-V-processes” per iteration 
[ID51]. 
5. Handle risk management, requirements traceability and 
verification within the development team as part of the 
software process. Moreover, automate risk identification on 
each code commit [ID52]. 
6. Introduce requirement workshops and backlog grooming 
[ID53]. 
7. Introduce IaC [ID53] but observe infrastructure compliance 
risks [ID45, ID49]. 
8. Use a common ticketing system for quality review and 
approval, covering software items, configuration 
documents, risk identification, verification items, user 
stories or requirements, code commits, build versions, 
packages, deployments, tests and defects [ID55]. Moreover, 
link them together for traceability [ID54]. 
9. Story-mapping of high-level requirements linked to such 
work items [ID57]. 
10. Enable tight tool integration [ID56] and facilitate blockchain 
infrastructure to share a common truth in an immutable and 
decentralized manner via a distributed ledger [ID60] across 
linked artifacts. 
11. Extend Git workflow and branch strategy to support 
compliance [ID58]. 
12. Establish groups of people with proper mentor and 
coaching capabilities with allocated effort (e.g. 20%) to 
facilitate culture and organizational change needed for 
DevOps, rolling out changes in small doses, called “tiger 
teams”' in [ID59]. 
Extending DevOps is an organizational and technical 
complex set of tasks where resources must be available in terms 
of personnel and budget. It is a management responsibility to 
ensure proper commitment as required by ISO 13485 Chapter 5 
Management responsibility. 
DevOps tools and artifact change management. The 
precision for traceability of the existing tools used for DevOps is 
not necessarily realized to support regulatory requirements 
[ID61]. As a minimum, a common unique identifier must be part 
of every artifact for traceability, and the audit trails and history 
must be kept secure. The tracking identifier should be used 
across all tools and be possible to link hierarchically, and 
developers should be guided in workflows and standard 
templates [ID61]. For regulators to approve both the quality 
system and the correctness of the software, such a bridge 
between tools is necessary. The blockchain concept is an 
interesting perspective that could be utilized [ID62], e.g. 
introducing smart contracts between different DevOps tools. 
IBM HealthChain [1] is an initiative to explore blockchain 
technology that demonstrates the transformative capability of 
blockchain in a healthcare context. 
RQ4: What organizational and operational 
strategies and factors should be considered 
when DevOps and ISO 13485 are 
implemented? 
Err and err and err again but less and less and less 
Danish poet and scientist Piet Hein aptly expressed his view 
on the road to wisdom with these words. In a way, it describes 
the philosophy behind short software cycles and agile 
requirements planning, where “Fail fast, fail early” is an 
observed mantra [ID70, ID71]. Software development is a 
complex endeavor, often to such an extent that organizations 
and people must contra-intuitively adapt to the process. 
However, it could be worthy for those who endure and are 
willing to change. In particular, four key strategies were 
proposed in [ID75] to successfully implement DevOps in a 
regulated setting: 
1. Foster a community, change the culture to establish 
collaborative channels, and merge traditional mindsets and 
agile. They are complementary, not in conflict. 
2. Co-create a standard DevOps IT platform also supporting 
traditional development. 
3. Improve, iterate and gather insights, key performance. 
Grow process over time. 
4. Over-communicate, tell stories, share success, and show 
data. 
Transitioning to a regulated DevOps approach must begin 
with small steps and adopt along the way, the strategy must be 
followed up with tactical implementations. First, the QMS must 
be robust to agile mindsets and agile change management 
procedures [ID64]. Then, one can start with the basic code 
check-in procedures, continue with introduction of collaboration 
suites, wikis, issue tracking and follow up with automated CI/CD 
and automated verification [ID75]. Finally, a focus on reducing 
the cycle time will lead to faster anomaly discovery and 
ultimately improved quality of products and lives [ID75]. 
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Culture. DevOps is one way to transition from feature-boxed 
to time-boxed release strategies [ID70] that allows to understand 
that software cannot be completely defined in advance [ID68]. 
Organizational culture must foster and allocate time for iterative 
learning and experimentation [ID68], some allocate up to twenty 
per cent effort for this activity [ID70]. The minimum viable 
product concept (MVP) means that a product is available at a 
very early stage in development, it is an agile approach in which 
faster innovation and better usability is reported [ID68]. 
Moreover, the cultural transition should be supported by 
coaching and mentoring [ID63]. To do so, one could establish 
dedicated “tiger teams” of internal expertise, rolling out portions 
of changes [ID76]. 
Compliance. Introduce regulators and auditors as 
stakeholders in the release cycle who can address the audit, risk, 
compliance and security requirements [ID65]. Depending on the 
product risk classification, one must consider if such 
stakeholders are external to the organization or internal 
compliance officers. Such stakeholders can properly guide and 
coach developers to maintain regulatory compliance with their 
field of expertise. Proper risk management is also required by 
regulations and should be a natural part of the requirements 
management process. Thus, each mitigation action that involves 
product feature change or addition must be verified for its 
intention, and full traceability must be maintained as risk 
management activities are often part of regulatory audits [ID66]. 
Requirements workshops. Let all project stakeholders 
meet for initial engineering and backlog adjustments [ID78]. This 
should ideally be done as often as possible, e.g. before each 
sprint starts. 
Standards development. Possible flaws of tools in the QMS 
and development environment should be addressed in the risk 
analysis of the software validation planning, and also be 
extended to be a part of IEC 62304 as suggested by [ID72]. 
Although, definition of “good enough documentation” is not 
explicitly defined in the regulations and standards, it is merely 
up to the QMS to describe. In fact, regulatory support of DevOps 
practices could be improved according to [ID72]. 
Where DevOps might not be applied. It is important that 
organizations understand their value streams and customer 
demands, as businesses that do not require frequently updated 
software to meet customer demand are not likely to gain real 
business value from transitioning to DevOps [ID77]. Therefore, 
massive, complex and monolithic projects will most likely 
adhere to spiral or waterfall delivery processes. Finally, 
businesses that still create their value from external software 
processes will need to have a clear vision to how DevOps can 
help [ID77] before embracing such an approach. 
4 DISCUSSION 
4.1  Compliance 
DevOps in regulated environments, especially within medical 
device development, brings continuous focus on areas of 
compliance, risk management and safety, and is seen as superior 
to plan-based development frameworks (V-models, waterfall-
models). One might easily assume that combining traditionally 
long-running approval cycles, waterfall development processes 
and regulated development is incompatible with shorter-cycles, 
open software and agile development. We have found some 
examples of the opposite, supported by industry experience [3]. 
Other agile approaches like XP, Scrum, and FDD are evaluated in 
terms of compliance by Alsaad et al. [2] and they were found 
applicable to some extent. We believe DevOps could serve as an 
even better form of agile approach due to its operational nature: 
servicing, post-market surveillance and de-commissioning are 
necessary medical product phases leaning towards the Ops of 
DevOps. 
DevOps seems to be vital for being able to adapt new 
regulations, and therefore increase competitive capabilities. 
Introducing DevOps in medical device development could lead to 
several improvements compared to traditional development 
reported in the sources: feedback loops are extended and 
accelerated; reduction of cost in time and human resources; and 
a reduction in defects which could lead to both better quality and 
better fulfillment of user needs, ultimately better life quality. 
However, to change an organization from a plan-driven- to an 
agile approach is an organizationally- and technically complex 
task. DevOps is to transition from feature-boxed to time-boxed 
release strategies and understanding that software cannot be 
completely defined in advance. An organization must introduce 
new agile processes supporting short planning cycles and 
structured requirements management, as well as more 
automation, more tools and more testing which imply cultural, 
organizational and technical impacts. 
The DevOps process itself is not necessarily subjected to 
regulatory approval but must fulfill requirements in an approved 
QMS. In this sense, one can find an interesting approach called 
Q-Interface, that blends agile artifacts with such requirements 
while still keeping regulatory compliance with ISO 13485 [13]. 
Some sources promote the idea of including regulators as 
stakeholders, but this cannot substitute requirements of having 
an approved QMS. Having a bridge between statically approved 
QMS and dynamic DevOps processes can be realized through 
such an interface. Merging requirements for records (process 
evidence) and DevOps artifacts should be established by an 
organization. In this sense, Wagenaar et al. [28] identified 55 
agile artifacts in 19 agile teams. The artifacts were mostly results 
of internal governance in teams and seldom a result of external 
requirements. They concluded that the more an agile team 
operates according to DevOps, the more it benefits from its own 
artifacts. Adding these artifacts to quality interfaces could 
contribute to compliance work [13]. 
4.2  Tooling 
There is probably not one single tool that covers all use cases 
and actors completely, yet several toolsets are in use in a 
development process, e.g. source control systems, requirement 
management systems, and different verification tools. Ebert et al. 
[8] present a compiled list of such popular tools, with probably a 
myriad others competing for customers. However, these tools 
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must provide traceability across tools and process borders for 
compliance. One solution is to provide unique identifiers to 
software items for such traces and introduce blockchains of trust 
between tools. Cognizant and IBM are companies presenting 
such ideas [1,33]. 
One might argue that DevOps means more automation and 
tooling, and that the tooling itself contribute to more efficient 
processes. However, the regulatory constraints to medical device 
development are not only solved by adding more software tools 
to the process, as considerations for the processes, activities and 
tasks are complex organizational issues that must be in 
compliance. It means keeping document control, procedures for 
the control of changes, audit records, risk management and 
resource prioritization, to name a few of the chapters of ISO 
13485 standard which must be addressed in a QMS and reflected 
in the organization. 
According to ISO 13485:2012 Chapter 4.2.3 Control of 
documents and ISO 13485:2012 Chapter 6.3 b) Infrastructure, all 
documentation activities that are related to product quality must 
be under control and the organization must determine, provide and 
maintain the infrastructure needed to achieve conformity to 
product requirements. This sets requirements to CI/CD stacks 
such as audit trails, backup/restore activities and security, to 
mention a few. Such requirements and their control activities are 
documented in a software validation plan and records issued in 
conformity of a QMS. All CI/CD tools and the introduction of 
DevOps are, therefore, a management responsibility and cannot 
be left to development groups alone to decide. 
4.3  Code first 
We have described several key enabling technologies for DevOps 
transition, like a cloud-native approach, compliance as code and 
infrastructure as code. A Cloud-native transition involves 
infrastructure-as-code (IaC), enabling accelerated deployment 
and repeatable, automatable testing of each feature branch. In 
regulated domains, this could be backed by the concept of 
Compliance-as-code (CaC), exemplified by the open source tool 
https://www.inspec.io/. According to Bird [5], compliance as 
Code (CaC) can be seen as the process of building compliance into 
development and operations. This would allow organizations to 
automate configuration changes by making them repeatable and 
standardized as required by IEC 62304 (Chapter 5.8.5 and 5.8.8). 
IaC and CaC can be seen as software or configuration items 
that must be identified, version-controlled and securely 
controlled (IEC 62304 Chapter 5.1.10 and 8.1). Traceability 
requirements can be enforced to these types of artifacts. We 
found that organizations invest in toolsets consisting of several, 
loosely integrated solutions and that the precision for 
traceability is not necessarily enough to support regulatory 
requirements. A common unique identifier is a minimum 
requirement of every artifact for traceability. In this line, the 
concept of defining compliance as code with smart contracts is 
an emerging use of blockchain technology. As mentioned before, 
IBM HealthChain [1] is an interesting initiative to implement 
blockchain and DevOps in a health context. 
4.4  Limitations and threats to validity 
Our review is based on sources of academic and grey literature 
to provide a state-of-the-art on the topic. Therefore, some 
selected sources are based on expert opinions and could be 
biased towards popular trends and products. The authors’ pre-
assumptions, background and knowledge could further 
emphasize this. The data extraction procedures could be too 
narrow in terms of extracting borderline sources or sources with 
conflicting views that are not captured by the search strings and 
inclusion criteria. As the field is rapidly moving forward, it is 
assumed that non-written knowledge could be substantial and 
should be captured by other methods. The low amount of 
sources also reveals that more research is needed in this field. 
4.5 Further work 
Since DevOps is an industry trend, face-to-face interviews and 
surveys could be conducted to provide additional empirical 
evidence that support the findings. Further research is also 
needed to explore the levels of good enough documentation and 
how to properly link internally created process documentation 
with regulated requirements. 
As future work, it would also be interesting to expand this 
MVLR to cover the concepts related to DevOps. Instead of 
focusing the search strings on the DevOps term, that string 
might be expanded to include continuous integration, 
continuous deployment, and continuous delivery. 
5 CONCLUSIONS 
As practitioners and researches learn from implementing 
DevOps in regulated environments, specifically medical devices, 
we found that there are many challenges to overcome, but 
benefits to harvest. Challenges include re-allocation of resources 
for more intense collaboration and test activities, more planning 
and overlapping activities, and adjusting organizational cultures 
and processes for changing work structures. Although potential 
benefits include reduction of cost, time and human resources, no 
quantitative evidence was found. Moreover, reduction in defects, 
increased product quality, compliance and better fulfillment of 
user needs are also reported benefits. We also found evidence 
that supports the claim that DevOps is particularly suited for this 
context, and a checklist based on descriptive synthesis from our 
MVLR is presented. In particular, RQ4 describes considerations 
necessary to implement DevOps in an ISO 13485 regulated 
environment. 
Businesses that develop under a regulated environment must 
understand their management responsibility. All activities that 
are related to product quality must be under control and the 
organization must determine, provide and maintain the activities 
needed in order to achieve conformity to product requirements. 
Introduction of DevOps in a medical context cannot be left to 
development teams alone to decide but must be anchored in top-
level management and quality policies. 
A Sources List 
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